Search for: "Watson v. Johnson"
Results 41 - 60
of 122
Sorted by Relevance
|
Sort by Date
15 Mar 2019, 4:00 am
"As to considering hearsay evidence in an administrative hearing, the Appellate Division said that "hearsay is admissible as competent evidence in an administrative proceeding, and if sufficiently relevant and probative may constitute substantial evidence even if contradicted by live testimony on credibility grounds" [see Matter of Watson v New York State Justice Ctr. for the Protection of People with Special Needs, 152 AD3d 1025]. [read post]
15 Mar 2019, 4:00 am
"As to considering hearsay evidence in an administrative hearing, the Appellate Division said that "hearsay is admissible as competent evidence in an administrative proceeding, and if sufficiently relevant and probative may constitute substantial evidence even if contradicted by live testimony on credibility grounds" [see Matter of Watson v New York State Justice Ctr. for the Protection of People with Special Needs, 152 AD3d 1025]. [read post]
31 Jul 2011, 8:54 am
In the Johnson's case, the Louisiana Supreme Court used the factors laid out in a 1985 Louisiana Supreme Court case, Watson v. [read post]
3 Apr 2009, 4:50 am
: Scinopharm Taiwan Ltd v Eli Lily & Co (PatLit) Naglazyme (Galsulfase) - Brazil: Federal Court of the First Region orders government to supply unapproved drug Naglazyme (IP tango) Plavix (Clopidogrel) – US: Bristol-Myers Squibb to pay $2.1 million to settle FTC claims it issues misleading statement about proposed Plavix patent deal with Apotex, violating court orders from earlier anti-trust cases (Law360) Razadyne (Galantamine) – US: Johnson &… [read post]
11 Jun 2012, 6:08 pm
The case, Johnson et. al. v. [read post]
8 May 2017, 6:27 am
By Marjorie Johnson, J.D. [read post]
9 Apr 2009, 7:52 am
(Part I - Patent Circle) (Part II – Patent Circle) Indian biogenerics on an upswing – US Promoting Innovation and Access to Life-Saving Medicine Act (Patent Baristas) US: Anti-reverse payment legislation Protecting Consumer Access to Generic Drugs Act of 2009 introduced in the House (Patent Docs) US: CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent… [read post]
12 Jun 2017, 3:00 am
The US Supreme Court felt bound by Brulotte v. [read post]
21 Sep 2016, 5:48 am
Johnson, 61 Cal.4th 734, 767) California Court of Appeals – Fourth District 2015) [`The admission of photographs lies within the trial court's discretion and will not be disturbed absent an abuse of that discretion’].)People v. [read post]
4 Feb 2013, 10:16 am
Johnson, 810 A.2d 871, 875 (D.C. [read post]
26 Apr 2007, 2:18 pm
Anderson has this article on Watson v. [read post]
Law Review: Met Gate / Hackgate – whatever you call it – The Coulson story isn’t going to go away…..
6 Sep 2010, 8:52 pm
Why only in opposition has Alan Johnson finally decided to make some noise? [read post]
2 May 2011, 2:49 pm
Professor Rebecca Tsosie Part 2: The Doctrine of Discovery in the United States, New Zealand, and Beyond View presentation here Johnson v. [read post]
17 Jun 2009, 3:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Gene patenting debate continues: UCLA v USPTO (Patent Docs) (Patent Docs) (PatentlyBIOtech) (Patent Docs) (IP Watchdog) US: FTC issues highly anticipated report on follow-on biologics; report concludes that special legislative exclusivity incentives are largely unwarranted for innovators and generics (FDA Law Blog) (Patent Docs) (Patent… [read post]
17 Jun 2009, 3:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Gene patenting debate continues: UCLA v USPTO (Patent Docs) (Patent Docs) (PatentlyBIOtech) (Patent Docs) (IP Watchdog) US: FTC issues highly anticipated report on follow-on biologics; report concludes that special legislative exclusivity incentives are largely unwarranted for innovators and generics (FDA Law Blog) (Patent Docs)… [read post]
26 Aug 2014, 11:17 am
“You have a grand gift for silence, Watson. [read post]
18 Jan 2010, 8:18 pm
In what some may call a blistering assault on the trial prosecutor, the Florida Supreme Court in Paul Beasley Johnson v. [read post]
25 May 2010, 9:56 am
Paul Johnson, of McCorkle & Johnson, LLP, Savannah. [read post]
25 May 2010, 9:56 am
Paul Johnson, of McCorkle & Johnson, LLP, Savannah. [read post]
16 Dec 2009, 7:00 am
Evans v. [read post]
